Katsuto Takenaka - Concepedia

Author

Katsuto Takenaka

Also Known As

Hiroshi Kawabata, K Takenaka, KATSUTO TAKENAKA, Katsuto TAKENAKA, Katsuto Takenaka, Naohiro Sekiguchi, for Fukuoka Blood and Marrow Transplant Group (FBMTG)

248

Publications

6.8K

Citations

H-Index

101

Concepts

All Affiliations

Kyushu University Kyushu University Hospital Ehime University Hamanomachi Hospital Okayama University

About

Katsuto Takenaka is an author at Kyushu University specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	48	3.9K
2	Cell Biology	14	17	3K
3	Health Sciences	11	11	1.9K
4	Blood Transplantation	10	10	499
5	Public Health	3	3	84

Katsuto Takenaka

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
Stem cell gene expression programs influence clinical outcome in human leukemia Kolja Eppert, Katsuto Takenaka, Eric R. Lechman, Nature Medicine Hematological MalignancyCell TherapyHuman LeukemiaMedicineStem Cell Mobilization	2011	1K
Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells Katsuto Takenaka, Tatiana K. Prasolava, Jean Wang, Nature Immunology Induced Pluripotent Stem CellMedicineGeneticsStem Cell MobilizationStem Cell Transplantation	2007	486
TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells Yoshikane Kikushige, Takahiro Shima, Shin‐ichiro Takayanagi, Cell stem cell Hematological MalignancyCell TherapyMedicineMalignant Blood DisorderImmunology	2010	475
Self-Renewing Hematopoietic Stem Cell Is the Primary Target in Pathogenesis of Human Chronic Lymphocytic Leukemia Yoshikane Kikushige, Fumihiko Ishikawa, Toshihiro Miyamoto, Cancer Cell Hematological MalignancyMedicineStem Cell MobilizationMalignant Blood DisorderImmunology	2011	301
A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression Yoshikane Kikushige, Toshihiro Miyamoto, Junichiro Yuda, Cell stem cell Hematological MalignancyCell TherapyMixed-phenotype Acute LeukemiaMyeloid NeoplasiaLeukemic Progression	2015	273
FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD–specific STAT5 activation Goichi Yoshimoto, Toshihiro Miyamoto, Siamak Jabbarzadeh‐Tabrizi, Blood	2009	256
Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor Yasuo Mori, Hiromi Iwasaki, Kentaro Kohno, The Journal of Experimental Medicine	2008	195
Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group Katsuto Takenaka, Tetsuya Nishida, Yuki Asano‐Mori, Biology of Blood and Marrow Transplantation Cell TherapyTransplantation MedicineImmunologyCytomegalovirus ReactivationImmunotherapy	2015	190
Human Flt3 Is Expressed at the Hematopoietic Stem Cell and the Granulocyte/Macrophage Progenitor Stages to Maintain Cell Survival Yoshikane Kikushige, Goichi Yoshimoto, Toshihiro Miyamoto, The Journal of Immunology	2008	177
Reinforce the antitumor activity of <scp>CD</scp>8<sup>+</sup> T cells via glutamine restriction Shogo Nabe, Takeshi Yamada, Junpei Suzuki, Cancer Science	2018	167

Page 1